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Bruno Geier, MD,a Sara Olbrich, MD,a Letterio Barbera, MD,a Markus Stücker, MD,b and
Achim Mumme, MD,a Bochum, Germany
Purpose: The intraoperative classification of recurrent veins at the saphenofemoral junction as neovascularization is based
on certain macroscopic criteria. The validity of this neovascularization identification by the surgeon was evaluated by
histologic and immunohistochemical examinations of the resected veins as the gold standard.
Methods: One hundred-four patients (mean age 57 10.9 years) with 130 affected extremities underwent redo surgery of
the saphenofemoral junction for recurrent varicose veins at a mean of 12.0  7.9 years after the initial stripping of the
greater saphenous vein. The surgeon used intraoperative findings to classify the recurrent veins as neovascularization
(group A), no neovascularization (group B), or unclear findings (group C). The resected veins then underwent histologic
and immunohistochemical examinations and were again classified into the same three groups (a, neovascularization; b, no
neovascularization; c, unclear) according to the histologic results.
Results:The operating surgeon correctly recognized 16 (41%) of 39 histologically proven neovascularizations, whereas 22
(56%) were not identified. In contrast, 66 (84%) of 79 cases with no neovascularization were correctly identified during
the operation. A definite classification by macroscopic criteria was not possible in 4 cases (3%) and the histologic
examinations revealed unclear findings in 12 cases (9%). The macroscopic neovascularization identification had a
sensitivity of 42.1% and a specificity of 85.7%. The positive predictive value reached 59.3% and the negative predictive
value, 75%.
Conclusion: The validity of intraoperative neovascularization identification is poor, but the surgeon is able to recognize
non-neovascularization recurrences with relatively high accuracy. The etiologic classification of recurrent veins at the
saphenofemoral junction should not be solely based on macroscopic criteria. ( J Vasc Surg 2005;41:64-8.)In recent years, neovascularization has been increasingly
recognized as a cause of recurrent insufficiency at the saphe-
nofemoral junction (SFJ) after the greater saphenous vein
(GSV) has been stripped. The definition of recurrent insuffi-
cient veins at the saphenofemoral junction as neovasculariza-
tion relies on several macroscopic criteria: tortuosity of the
vessels with an atypical junction to the femoral vein, the
presence of scar tissue around the vessels, and the lack of valves
within the lumen of the recurrent veins. In several studies,
neovascularization is identified by the surgeon intraopera-
tively based on these macroscopic criteria.1-4
The other cause of recurrent insufficiency at the SFJ,
from which neovascularization has to be differentiated, is a
technically incorrect initial operation that leaves a long
saphenous stump or inguinal branches of the saphenous
vein with persistent reflux. It is unclear how reliable the
macroscopic, intraoperative differentiation between these
two causes of saphenofemoral recurrence actually is. We
therefore conducted a prospective study to evaluate how
well the macroscopic classification of the recurrent veins by
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64the operating surgeon correlates with the histologic
workup of the resected vein specimen.
PATIENTS AND METHODS
The study included 104 consecutive patients (23 men,
81 women, mean age 57.0 10.9 years) and 130 legs with
symptomatic recurrent varicosities after the GSV was
stripped, in which duplex ultrasound scanning showed a
recurrent vein at the SFJ with a diameter of more than 5
mm. Patients with recurrent veins at the SFJ with a diame-
ter of less than 5 mm were not included in the study. These
patients were treated with duplex ultrasound-guided scle-
rotherapy of their varicosities.
The mean diameter of the recurrent veins at the SFJ in
the study group measured by duplex ultrasound scan was
7.2  1.3 mm. According to the CEAP classification,5
clinical class C2 (varicose veins) was present in 76 legs
(58%), C3 (edema) in 30 legs (23%), C4 (skin changes) in
14 legs (11%), C5 (healed ulcer) in 4 legs (3%), and C6
(active ulcer) in 6 legs (5%).
The initial operation had been performed a mean of
12.0  7.9 (median 10, minimum 1, maximum 50) years
previously. Neither the institution where the initial opera-
tion took place nor the surgeon involved primarily were
recorded in order to preclude any bias in assessing the cause
of recurrence during the present study.
The redo SFJ operation was performedwith a standard-
ized technique. A lateral approach in the groin with a
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initial operation. With the common femoral artery as a
landmark, the common femoral vein was visualized. After
identifying the junction of the recurrent veins with the
common femoral vein, the vessels were dissected out pe-
ripherally as far as possible. Care was taken to resect a
segment of the recurrent vein of at least 2 cm in length,
which was then stored in formalin. A few of the first
specimens demonstrated damage of their tissue structure
that hindered histologic examination, so clamping and
traumatizing of the resected vein segments was avoided
during the rest of the study period.
At the end of the procedure, the surgeon determined
the etiology of the recurrent veins based on the macro-
scopic criteria for neovascularization (Table I) and classified
them into one of three groups:
● group A: neovascularization
● group B: no neovascularization
● group C: unclear whether A or B
Group C had to be chosen in cases where the macroscopic
features of the recurrent veins were conflicting and the
surgeon was not able to distinguish between neovascular-
ization and residual vessels as a cause for the recurrence.
The vein specimens were then evaluated by light mi-
croscopy (hematoxylin and eosin and elastica-Van Gieson
staining) as well as by immunohistochemical marking with
the S100-antigen (Dako, Hamburg, Germany), according
to the criteria outlined by Nyamekye et al2 (Table II). A
typical histologic finding for a recurrence caused by a
residual vessel is shown in Fig 1, and Fig 2 depicts the
findings in the case of neovascularization.
As with the intraoperative macroscopic classification,
the histologic and immunohistochemical findings were
used to divide specimens into the same three groups (group
a, neovascularization; group b, no neovascularization;
group c, unclear whether a or b). Since the unclear findings
Table I. Macroscopic criteria of neovascularization
● atypical origin of the vessel at the femoral vein
● presence of scar tissue around the vessel and at the junction
with the femoral vein
● tortuosity of the vessel
● atypical ramification in several side branches
● thin vessel wall
● difficult dissection
● lack of vein valves
Table II. Histologic and immunohistochemical criteria
of neovascularization
● incomplete structure of the vein wall
● lack of vein valves
● lack of intramural nerve fibers
● bizarre form of the vessel lumen
● presence of scar tissue around the vessel(group C and c) could not be safely classified as eitherneovascularization or residual veins, they were excluded
from the validity assessment.
The remaining results were evaluated statistically with
the histologic and immunochemical examination regarded
as the gold standard. The sensitivity and the specificity of
the neovascularization identification by the operating sur-
geon were calculated as well as the positive and negative
predictive values.
RESULTS
In the intraoperative assessment of recurrent varicose
veins at the SFJ, the classification of group A was chosen in
32 cases (25%) and group B in 94 (72%). In 4 cases (3%), a
definite classification was not possible.
The histologic and immunohistochemical examination
designated 39 cases (30%) to group a and 79 cases (61%) to
group b; 12 specimens (9%) could not be designated clearly
to either group (group c) (Table III). These samples dem-
onstrated varying degrees of tissue damage, with destruc-
tion of the wall structure of the containing veins, presum-
ably by clamping or traumatic dissection. The tissue
damage precluded correct histologic and immunohisto-
chemical evaluation and classification.
The operating surgeon correctly identified only 16
(41%) of the 39 cases of neovascularization found by histo-
logic and immunohistochemical examination. In 22 cases
(56%), the assessment was false-negative, and the finding
was unclear in 1 (3%). On the other hand, 66 (84%)of the
79 recurrences not caused by neovascularization were cor-
rectly identified intraoperatively. A false-positive assess-
ment occurred in 11 (14%) of these cases, and in 2 (2%), a
definite intraoperative classification had not been possible.
When determining the validity of the intraoperative
identification of neovascularization by the surgeon, a sen-
sitivity of 42.1% and a specificity of 85.7% were calculated.
The positive predictive value reached 59.3%, and the neg-
ative predictive value, 75.0%.
DISCUSSION
In the past years, neovascularization has been recog-
nized as a cause of recurrence after the GSV has been
stripped. In our own experience, it was found in 26% of
Table III. Results of the macroscopic (A-C) and
histologic (a-c) classification
H
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di
ng
s(
a–
c) Macroscopic findings (A-C)
Group
A
(n  32)
B
(n  94)
C
(n  4)
a (n39) 16 22 1
b (n79) 11 66 2
c (n12) 5 6 1
A, a, Neovascularization; B, b, no neovascularization; C, c, unclear.patients undergoing SFJ revision,6 but a recent report
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redo operations.7 The other possible cause for recurrent
varicose veins after stripping are residual parts of the GSV or
its branches left in continuity with the deep vein at the
initial operation that allow persistent reflux into the super-
ficial venous system. Because the latter type of recurrence
can be avoided by a correct surgical technique, it is impor-
tant to determine the actual rate of true neovascularization
that forms despite an appropriate initial operation and to
develop strategies to reduce its incidence. This is especially
important, because new techniques of endovenous GSV
obliteration by laser, radiofrequency, or foam claim to have
a lower rate of neovascularization compared with the classic
stripping operation.8-11
Neovascularization first forms months or even years
after the initial operation, as a study by Frings et al12
proved. In their group of 400 consecutive patients under-
going stripping of the GSV, no recurrent reflux was de-
tected 3 months postoperatively; however, at follow-up
after 4 to 5 years, the rate of recurrent reflux at the SFJ was
33.3%. Fischer et al13 used duplex ultrasound scanning to
evaluate the SFJ up to 34 years after the initial stripping
operation and found recurrent varicose veins in the groin in
60% of legs. These studies indicate that the rate of recurrent
reflux at the SFJ increases the longer the initial operation
dates back.
Even Langenbeck14 recognized that neovasculariza-
tion could compromise the outcome of varicose vein sur-
gery. One year after removing a segment of the GSV, he
found a newly formed vein in the excision scar that con-
nected the two remaining ends of the GSV. However, it is
only since the work of Glass4 that neovascularization has
again gained attention and become a topic of phlebologic
research.
Despite these improvements, the current knowledge
Fig 1. Example of a residual vessel with a three-layered structure
of the vein wall consisting of intima, media, and adventitia (van
Gieson stain, original magnification 25).concerning the pathophysiology of neovascularization hasadvanced only a little beyond the observations made by
Langenbeck more than 150 years ago. It is still unclear
which mechanisms are responsible for the formation of new
vessels at the SFJ. The type of suture used to close the GSV
stump as well as the free endothelium of the stump are
regarded as factors influencing neovascularization15; fur-
thermore, hemodynamic effects16 and the operation
trauma itself17 are described as causes. Fischer et al18 have
summarized the present state of neovascularization re-
search in an overview article.
Several studies have shown that synthetic barriers can
be effective in preventing neovascularization.17,19-22 The
barrier technique consists of the coverage of the ligated
GSV stump and the anterior wall of the femoral vein with a
nonresorbable synthetic patch. Such a procedure should be
considered if neovascularization at the SFJ is encountered
during the redo operation to minimize the potentially high
risk of varicose vein recurrence.
The intraoperative identification of neovascularization
is based on the criteria outlined by Glass.23 He describes
the findings typical of neovascularization: a thin-walled and
tortuous vessel surrounded by scar tissue and with an
atypical origin at the deep vein. If, in addition, there are
multiple venous channels originating from the deep vein,
the etiologic classification of the recurrent veins as neovas-
cularization can bemade with little doubt. This was the case
in most of the patients that were not included in the present
study. Duplex ultrasound scanning showed thin, refluxing
vessels at the SFJ with a diameter of less than 5 mm.
Because the intraluminal diameter of the GSV is a measure
of hemodynamic impairment and predicts the presence of
Fig 2. Example of neovascularization with multichannel thin-
walled tortuous vessels embedded in scar tissue. Most of these
vessels were only composed of endothelium, others contained a
thin, unstructured muscle layer beside endothelial cells. No mem-
brana elastica interna in the scar tissue was recognized. All vessels
stained negative for intramural nerves on S100 immunohisto-
chemistry (van Gieson stain, original magnification 25).critical venous incompetence,24 these vessels were not
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therefore did not undergo surgical revision.
In the clinical situation, it is usually the “single-channel”
recurrences that are regarded as hemodynamically relevant
and therefore undergo redo operation. Because of its rela-
tively large diameter, this particular form of neovasculariza-
tion can be hard to differentiate from a residual GSV stump
or inguinal branches of the GSV that have remained as the
result of a technically incorrect initial operation.
In fact, only 16 of the 39 cases of neovascularization
proved by histologic and immunohistochemical findings
were identified correctly in the present study. The operat-
ing surgeons falsely classified 22 neovascularizations as
residual genuine vessels. Those false-negative assessments
resulted mainly from a lack of scarring around the recurrent
vessels that led to the belief that that area had not been
touched at the initial operation. There were 11 false-positive
assessments where neovascularization was assumed by the
surgeon but could not be proven by histology. However,
there was a high rate of correct identification of cases with
no neovascularization: in 84% the intraoperative assessment
of a lack of neovascularization was proven by histology and
immunohistochemistry.
It seems to be easier for the operating surgeon to
identify a situation where neovascularization is absent and
the recurrence is caused by residual genuine vessels than it
is to correctly asses the presence of true neovascularization.
There are occasional cases, however, where a residual GSV
stump can resemble neovascularization, especially if there is
a lot of scar tissue around it and if the stump itself shows
varicose degeneration.
With a positive predictive value of only 59.3%, the
validity of the intraoperative identification of neovascular-
ization is low. This implies that direct inspection at surgery
is not a reliable diagnostic tool for the presence or absence
of neovascularization. Because the presence of neovascular-
ization might prompt a certain therapeutic strategy, such as
the use of a barrier technique, it is desirable to improve the
correct identification of newly formed veins. This might be
possible by trying to correlate each single macroscopic
criterion with the histologic findings and evaluating which
criterion or combination of criteria is the most predictive of
neovascularization.
Furthermore, the preoperative identification of neovas-
cularization needs to be improved. Neither duplex ultra-
sound scanning nor phlebography has been evaluated to
see if they yield valid results in terms of correctly differen-
tiating neovascularization from residual veins. While the
presence of several thin vessels originating directly from the
deep vein is a typical ultrasound pattern of neovasculariza-
tion, the correct classification of recurrent veins larger than
5 mm might be as unreliable with duplex ultrasound scan-
ning as the macroscopic classification proved to be. Here,
too, prospective studies correlating the ultrasound picture
with the histologic findings might help in identifying the
ultrasound pattern that is the most predictive for neovas-
cularization, thereby helping to recognize neovasculariza-
tion prior to surgery.Our findings also suggest that studies comparing the
incidence of neovascularization among different forms of
treatment, such as endovenous obliteration and the classic
stripping of the GSV, cannot base their identification of
neovascularization on macroscopic or ultrasound criteria
alone but must validate it with histologic evaluation of the
recurrent veins to correctly recognize the incidence of true
neovascularization.
In summary, our study indicates that the only valid tool
so far for the identification of neovascularization remains
the histologic and immunohistochemical workup of the
resected veins described by Nyamekye et al.2
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